IVERIC bio, Inc. Common Stock (ISEE)

ISEE was delisted on the 10th of July, 2023.

• Market cap: $5.51B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.

Employees: 163